Novo Nordisk A/S (NOVO.TO) Dividend Yield, History & Forecast

Novo Nordisk A/S (NOVO.TO) is a Drug Manufacturers - General company in the Healthcare sector listed on the Toronto Stock Exchange. It pays a current dividend yield of 4.23% ($11.70 per share annually (TTM)). The trailing twelve-month payout ratio is 44.6%; the market capitalization is approximately $60.93B. Review NOVO.TO dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

Frequently Asked Questions about Novo Nordisk A/S (NOVO.TO)

What is Novo Nordisk A/S's dividend yield?
Novo Nordisk A/S (NOVO.TO) pays a current trailing twelve-month dividend yield of 4.23%, which works out to $11.70 per share annually based on the most recent payout schedule.
Is Novo Nordisk A/S a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Novo Nordisk A/S in?
Novo Nordisk A/S (NOVO.TO) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What is Novo Nordisk A/S's dividend payout ratio?
Novo Nordisk A/S (NOVO.TO)'s trailing twelve-month dividend payout ratio is 44.6%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.